Vikram Pattanayak

This inventor holds 10 USPTO granted patents and 2 published patent applications and 1 EPO patent. Top assignee: The General Hospital Corporation. Active years: 2016-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vikram Pattanayak. Retrieved from https://idiyas.com/inventor/vikram-pattanayak-pvcjzdip

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 2)

% Patents Active = 90.0

EPO Patents = 1 (Patent Applications = 3)

Average Co-Inventor Count = 3.1

ph-index = 5

Forward Citations = 240(Granted Patents)

Company Filing History:

10 out of 3,076

The General Hospital Corporation

patents

Years Active: 2016-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12601009 - HIGHLY SENSITIVE IN VITRO ASSAYS TO DEFINE SUBSTRATE PREFERENCES AND SITES OF NUCLEIC-ACID BINDING, MODIFYING, AND CLEAVING AGENTS (2026-04-14),

2. 11976324 - Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents (2024-05-07),

3. 11898203 - Highly sensitive in vitro assays to define substrate preferences and sites of nucleic-acid binding, modifying, and cleaving agents (2024-02-13),

4. 11845987 - Highly sensitive in vitro assays to define substrate preferences and sites of nucleic acid cleaving agents (2023-12-19),

5. 11060078 - Engineered CRISPR-Cas9 nucleases (2021-07-13),

6. 10633642 - Engineered CRISPR-Cas9 nucleases (2020-04-28),

7. 10526591 - Engineered CRISPR-Cas9 nucleases (2020-01-07),

8. 10093910 - Engineered CRISPR-Cas9 nucleases (2018-10-09),

9. 9926546 - Engineered CRISPR-Cas9 nucleases (2018-03-27),

10. 9512446 - Engineered CRISPR-Cas9 nucleases (2016-12-06),

Title: Vikram Pattanayak: Innovator in Nucleic-Acid Research

Introduction

Vikram Pattanayak is a prominent inventor based in Wellesley, MA (US). He has made significant contributions to the field of nucleic-acid research, holding a total of nine patents. His work focuses on developing highly sensitive in vitro assays that enhance our understanding of substrate preferences and nucleic-acid interactions.

Latest Patents

Among his latest patents are innovative methods and compositions for performing highly sensitive in vitro assays. These assays are designed to define substrate preferences and off-target sites of nucleic-acid binding, modifying, and cleaving agents. His research aims to improve the accuracy and efficiency of nucleic-acid related assays, which are crucial for various applications in biotechnology and medicine.

Career Highlights

Vikram Pattanayak is affiliated with The General Hospital Corporation, where he continues to advance his research. His work has garnered attention for its potential to revolutionize the way scientists study nucleic acids and their interactions. His dedication to innovation in this field has established him as a key figure among contemporary inventors.

Collaborations

Some of his notable coworkers include J Keith Joung and Benjamin Kleinstiver. Their collaborative efforts have contributed to the development of groundbreaking technologies in nucleic-acid research.

Conclusion

Vikram Pattanayak's contributions to the field of nucleic-acid research through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in biotechnology and medicine.

Profile summary based on public USPTO records.